Neuspera Hires Courtney Lane to Lead Clinical and Regulatory Affairs
SAN JOSE, CA – February 1, 2023 — Neuspera® Medical, a medical device company developing miniaturized neuromodulation technology for patients with chronic illnesses, announces the hiring of Courtney Lane as Vice President, Clinical and Regulatory Affairs. The fast-growing early-stage company is progressing through enrollment of the second stage of its pivotal study (SANS-UUI) to evaluate the safety and efficacy of Neuspera’s technology in patients with urinary urgency incontinence associated with overactive bladder.
Dr. Courtney Lane has over 20 years of experience in neuromodulation device development and clinical trials. For the last 10 years, Dr. Lane worked as an independent consultant, working with cutting-edge medical device companies in the development of their devices and clinical and regulatory programs. Dr. Lane also served as Vice President of Clinical Affairs for Axonics Modulation Technologies, where she was responsible for the design and execution of the clinical program of a sacral neuromodulation device. Courtney was instrumental in the development of the Deep Brain Stimulation program at Boston Scientific, where she worked on all aspects of device development, from R&D and test designs to clinical trial designs and regulatory submissions. She then served as the Director of Clinical Science and Strategy, overseeing the development of Boston Scientific Neuromodulation’s clinical trial portfolio.
Steffen Hovard, CEO of Neuspera said: “We are excited to have Courtney Lane join Neuspera. Courtney brings a unique combination of skills and experiences that will help propel Neuspera forward – not to mention that she has a personality that makes it a pleasure to work with her.”
Dr. Lane earned her B.S.E.E. from Rice University, cum laude, and obtained her Ph.D. at the Massachusetts Institute of Technology in the Division of Health Sciences and Technology; she also worked as a researcher at Rice University, focusing on the development of hearing aid algorithms.
About Neuspera Medical
Neuspera Medical, Inc. is committed to developing implantable medical devices that will improve the lives of patients battling chronic illnesses. The Neuspera platform, which will include the Nuvella system, will provide patients and physicians new, and potentially earlier, treatment options that are less invasive and more adaptable. These therapeutic alternatives aim to help patients restore their health and well-being for a better quality of life.
Investor Relations and Media Contacts
Chief Financial Officer